Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions
NCT00778115
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Loperamide HCl 2 mg and simethicone 125 mg tablets
Sponsor
Ranbaxy Laboratories Limited